This article appeared in my feed this a.m.

When Filth Becomes Policy: An Investigation into the FDA’s “Acceptable” Levels of Contamination and Who Decides What We Eat
Sep 24, 2025
Americans expect regulation to protect their food supply. Yet the Food and Drug Administration’s own handbook makes plain a fact many find shocking: the federal government has published tables that spell out how much insect matter, rodent hair, mold, fly eggs and similar “extraneous” material may be present in common foods before the product is considered adulterated. These are called Defect Action Levels. They are specific, technical, and, to many citizens, morally unacceptable.

This is not a minor footnote. The FDA’s handbook and related compliance guidance list concrete thresholds for dozens of everyday items. For example:

Peanut butter: counts for insect fragments and rodent hair are set out in the handbook with numerical thresholds expressed per 100 gram subsamples.

Chocolate: FDA compliance guidance cites criteria such as an average of 60 or more insect fragments per 100 grams when six 100 gram subsamples are examined, or any single subsample with 90 or more. Rodent hair thresholds are specified separately.

Tomato products including sauces: the guidance lists fruit fly egg thresholds such as an average of 30 or more eggs per 100 grams, or 15 eggs plus one maggot per 100 grams, depending on test design.

Apple butter: the agency’s compliance policy guidance states that apple butter is considered adulterated when it has an average mold count of 12 percent or more across required subsamples, or specified rodent-hair and insect thresholds.

These numbers are not rumor or myth. They are published in federal documents that are available to the public and used by FDA inspectors as a basis for enforcement decisions.

The Sampling Problem: No One Checks Every Jar

A practical question follows. Who inspects a jar of peanut butter for rodent hair? How can a regulator or company know if your jar has 16 hairs instead of one? The answer is that the system relies on statistical sampling of lots, not inspection of every single retail unit. FDA inspection manuals and guidance describe sampling plans, subsampling rules, and laboratory analysis protocols. The defect tables are tied to those sampling schemes which determine whether a lot meets the standard.

Sampling is a well-established regulatory tool, but it has limits. It estimates an average condition across a production lot. It does not and cannot practically guarantee that every jar on a grocery shelf is defect free. That is a foundational tension in the system. We accept statistical assurance rather than unit by unit certainty.

Enforcement and the Myth of Dilution

If a sampled lot fails, what happens? Enforcement options include refusal of entry for imports, denial of interstate commerce for domestic lots, seizure, or recall actions. Importantly, official guidance and related agricultural manuals make clear that blending or diluting an adulterated lot to get it under a numerical threshold is not a lawful fix. The practice would itself be unlawful and potentially make the final food adulterated regardless. In short, you cannot lawfully throw the bad jar back in to dilute the defect count.

But the statement that the lot may be refused, seized, or recalled is not a full answer for the public’s concerns. Enforcement is reactive, often initiated by sampling programs, company self-testing, or consumer complaints. Because not every lot is sampled and not every complaint is acted on with the same vigor, contaminated units can and sometimes do circulate. The system’s reliance on sampling therefore leaves gaps, and those gaps matter when the subject is filth in food.

Why the FDA Adopted Defect Action Levels

The rationale the FDA gives for DALs is straightforward on its face. Some level of natural or unavoidable contamination occurs in large-scale agricultural production and processing, and the defect levels are intended to mark a point above which the agency will take regulatory action. The handbook repeatedly labels many of these defects as “aesthetic” rather than health hazards, asserting that the allowed levels present no inherent hazard to health. That is the legal and scientific justification used to maintain these tolerances.

There is practical truth to the FDA’s point. Complete elimination of every insect fragment or microscopic hair in bulk commodities requires extraordinary cost, new technologies, supply-chain redesigns, and potentially higher consumer prices. But the central question the public must ask is who the system serves. Are these tolerances calibrated to protect public health and consumer expectations, or are they calibrated to allow current industry practices to continue without economically painful changes?

Who Decides This? The Question of Influence

This investigation’s aim is not to make broad conspiracy claims, but to examine whether a process that sets tolerances affecting an entire nation should be insulated from the influences that shape regulatory policy. Concerns about industry influence at the FDA including lobbying, revolving-door employment, and resource constraints that favor industry proposals have been the subject of frequent investigative reporting and academic work. Studies have examined correlations between lobbying and regulatory outcomes. Investigative outlets have documented instances where agency discretion and industry pressure appear to have influenced enforcement and policy choices. Those findings suggest the public’s skepticism about who sets the limits is not entirely unfounded.

Those documented problems do not by themselves prove that specific DAL numbers were set to benefit industry, but they do justify the demand for transparency and independent review. When rules allow contamination in everyday food, the public deserves clear evidence that those thresholds were established only after impartial science, robust risk assessment, and meaningful public input.

What Consumers Deserve: Transparency, Choice, and a Reset

Given the facts above, here is what an accountable food-safety system should guarantee:

Full transparency. If defect action levels remain part of the regulatory toolkit, packaging should disclose the existence of the DALs that apply to that product category and what they mean in plain language. Consumers have a right to know what thresholds have been deemed acceptable for the foods they buy.

Reexamine the burden of proof and the standard. The starting presumption should be consumer health and consumer expectation, not economic convenience. If tolerances are retained, they must be grounded in modern risk assessments that explicitly prioritize public health, not cost minimization for producers.

Independent review and stronger sampling. The sampling programs and lab methods that underlie DALs must be open to independent audit. The FDA’s sampling protocols are technical and defensible, but their real-world application needs more public scrutiny and open-data disclosure so researchers and advocates can test whether the statistics correspond to reality on store shelves.

Guardrails against undue influence. Where credible studies and reporting point to industry influence on enforcement priorities, reforms are necessary. Stronger revolving-door restrictions, greater funding for independent science at the agency, and formal mechanisms for public participation in setting standards are essential. Research shows lobbying can affect regulatory decisions. The remedy is more transparency and checks on conflicts of interest, not secrecy.

The Bottom Line: We Were Never Asked

The core injustice here is democratic. No one asked Americans whether they wanted regulators to set thresholds for rodent hair, insect fragments, or fly eggs in their food. Those decisions were made in an expert-bureaucratic context, and while expertise matters, so too does consent and accountability. If tolerances remain in place, they must be defended publicly, explained plainly, and subject to democratic oversight. Or else they should be retired in favor of rules that prioritize consumer health and dignity.

We stated what good does it do to allow media to keep the people at odds with one another on topics that we cannot change. We can all agree that none of these contaminants are acceptable for us or our families and we have the power to boycott, protest outside these facilities and even outside of the FDA. We believe these actions are not just suggestible but a requirement to exact change on what the people, not as Democrats, not as Republicans but as a people who demand better for their health from those that we make wealthy.